SIGNA™ 7.0T

The SIGNA™ 7.0T with UltraG gradients delivers 7.0T contrast and SNR performance for improved diagnostic confidence, all with familiar state-of-the-art applications.

The SIGNA™ 7.0T with UltraG gradients delivers 7.0T contrast and SNR performance for improved diagnostic confidence, all with familiar state-of-the-art applications.

Scientific discovery meets clinical translation

Designed to overcome the limitations of many of today’s clinical MR systems, the SIGNA™ 7.0T* is a powerful new platform for advancing neurological research and clinical translation. Approximately five times more powerful than most clinical systems, SIGNA™ 7.0T is designed to detect subtle structures that may be significant for clinicians and researchers alike.

What’s New

SIGNA Magazine
Advancing MR imaging capabilities

Learn about how the University of Iowa is using the proven clinical technologies and powerful hardware advancements of the SIGNA™ 7.0T system to further propel MR imaging capabilities in their practice.

Learn More

  • UltraG gradients

  • Freedom and familiarity

Clinical Gallery

  • PROPELLER Motion-insensitive T2w imaging

  • Isotropic Cube T2 FLAIR

  • Co-registered Cube FLAIR and MP-RAGE

  • T2* Gradient Echo

  • 3D TOF Angiography

  • High resolution Susceptibility-Weighted Imaging

  • High resolution diffusion

  • Isotropic Diffusion Tensor Imaging

  • High-resolution Functional Imaging enabled by UltraG gradients

  • Patella Imaging

  • Volumetric Imaging with Cube

  • FSE-Flex (2-pt Dixon)

Supporting Materials

SIGNA™ 7.0T brochure

Download
Watch

SIGNA™ 7.0T webinar

Advanced neuro imaging platforms with 7.0T, high performance gradients and AI

FDA Clearance Press Release

Read More

*SIGNA™ 7.0T is FDA cleared in the USA. Not CE marked, not available for sale in all regions.